Welcome to New NREF Board Member Flagg Flanagan
The NREF is pleased to announce the appointment of Flagg Flanagan as public director to the NREF Board of Directors for a two-year term. Flanagan, a 30-year industry veteran, currently serves as chief executive officer and chairman of the board for DiscGenics, a clinical stage regenerative medicine company.
According to NREF Chair, Regis W. Haid, MD, FAANS, “The NREF is delighted to welcome Flagg Flanagan to the Board. His vast background in the industry brings to the Board a level of insight and expertise that will be instrumental as we continue to grow the NREF as the premier funder of groundbreaking neurosurgical research and provider of extraordinary educational opportunities for neurosurgeons.”